首页 | 本学科首页   官方微博 | 高级检索  
     


Predictors and Clinical Outcomes of Treatment Intensification in Patients with Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting
Affiliation:1. From Practice Fusion, San Francisco, California;2. Analysis Group, Inc, Boston, Massachusetts;3. Sanofi, Bridgewater, New Jersey;4. Bay West Endocrinology Associates, Baltimore, Maryland;5. Model Clinical Research, Baltimore, Maryland.;2. Sağlık Bilimleri Üniversitesi (University of Health Sciences) Keçiören SUAM, Department of Endocrinology and Metabolism, Ankara, Turkey;3. Sağlık Bilimleri Üniversitesi (University of Health Sciences) Dışkapı Yıldırım Beyazıt SUAM, Department of Internal Medicine, Ankara, Turkey;4. Sağlık Bilimleri Üniversitesi (University of Health Sciences) Dışkapı Yıldırım Beyazıt SUAM, Department of Endocrinology and Metabolism, Ankara, Turkey.;1. From the Department of Nutrition, Xinhua Hospital, School of Public Health, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;2. Department of Nephrology, Peking Union Medical College Hospital, and Chinese Academy of Medical Sciences, Beijing, China;3. Clinical Epidemiology Unit, Peking Union Medical College Hospital, and Chinese Academy of Medical Sciences, Beijing, China;4. Department of Cardiology, Kailuan Hospital Affiliated to Hebei United University, Tangshan, China;5. Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women''s Hospital & Harvard Medical School, Boston, Massachusetts;6. Department of Ultrasound, Kailuan Hospital Affiliated to Hebei United University, Tangshan, China;7. Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China;8. Department of Nutritional Sciences, The Pennsylvania State University, University Park, Pennsylvania;9. Department of Gastroenterology, Kailuan Hospital Affiliated to Hebei United University, Tangshan, China;10. Department of Anesthesiology, Kailuan Hospital Affiliated to Hebei United University, Tangshan, China;11. Department of Nutrition, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.;1. From the Division of Endocrinology, UCLA David Geffen School of Medicine, Los Angeles, California.;1. From the Division of Endocrinology, Diabetes, and Metabolism, UCLA David Geffen School of Medicine, Los Angeles, California.;1. From the Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada;2. Department of Family and Community Medicine, St. Michael''s Hospital, Toronto, Canada;3. Division of Endocrinology, University of Toronto, Toronto, Canada;4. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号